Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135522 · ClinicalTrials.gov registry record · Phase 2
Pilot of Zinc Acetate to Improve Chronic Cough
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT03135522: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT03135522 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03135522, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The Pilot of Zinc Acetate to Improve Chronic Cough (ZICO) is a study of 36 patients with chronic refractory cough that will be used to (1) assess if zinc acetate (150 mg/day) will improve patient reported measures of cough, (2) to establish if treatment with zinc acetate is well tolerated, and (3) to determine if the trial logistics are feasible.
Interventions
- DRUG Placebo oral capsule
- DRUG Zinc Acetate 50 Mg Oral Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2019-12-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03135522
The ClinicalTrials.gov registry entry for NCT03135522 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03135522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03135522 about?
NCT03135522 is a clinical study titled "Pilot of Zinc Acetate to Improve Chronic Cough". The Pilot of Zinc Acetate to Improve Chronic Cough (ZICO) is a study of 36 patients with chronic refractory cough that will be used to (1) assess if zinc acetate (150 mg/day) will improve patient reported measures of cough, (2) to establish if treatment with zinc acetate is well tolerated, and (3) t...
What is the current status of trial NCT03135522?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2018-02-14. Estimated completion is 2019-12-11.
What interventions are being tested in trial NCT03135522?
The interventions under investigation include: Placebo oral capsule (DRUG), Zinc Acetate 50 Mg Oral Capsule (DRUG).
Who is sponsoring clinical trial NCT03135522?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.